Heartflow (NASDAQ:HTFL) Director Jeffrey Lightcap Buys 40,000 Shares

Key Points

  • Director Jeffrey Lightcap bought 40,000 shares on Dec. 16 at an average price of $26.34 per share, a $1,053,600 purchase disclosed on an SEC Form 4.
  • Heartflow last reported EPS of ($1.46), missing estimates by $1.26 while revenue of $43.42 million was roughly in line with expectations.
  • Analyst sentiment is mixed — the stock has an average consensus rating of Hold with a $38.60 consensus target (four Buys, two Holds, one Sell) and recent price targets in the mid-$30s to $40 range.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) Director Jeffrey Lightcap acquired 40,000 shares of the firm's stock in a transaction that occurred on Tuesday, December 16th. The shares were bought at an average price of $26.34 per share, with a total value of $1,053,600.00. Following the acquisition, the director directly owned 40,000 shares in the company, valued at $1,053,600. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Heartflow Price Performance

Heartflow stock opened at $26.69 on Thursday. The firm has a 50-day moving average of $32.06. Heartflow, Inc. has a 1 year low of $25.38 and a 1 year high of $41.22.

Heartflow (NASDAQ:HTFL - Get Free Report) last posted its quarterly earnings results on Friday, September 19th. The company reported ($1.46) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($1.26). The firm had revenue of $43.42 million for the quarter, compared to analysts' expectations of $43.20 million.

Wall Street Analyst Weigh In




Several brokerages have weighed in on HTFL. Piper Sandler began coverage on Heartflow in a report on Tuesday, September 2nd. They issued an "overweight" rating and a $38.00 target price for the company. Zacks Research upgraded shares of Heartflow to a "hold" rating in a report on Wednesday, September 3rd. Weiss Ratings restated a "sell (d)" rating on shares of Heartflow in a report on Monday. JPMorgan Chase & Co. increased their price objective on shares of Heartflow from $36.00 to $40.00 and gave the company an "overweight" rating in a research note on Thursday, November 13th. Finally, Morgan Stanley assumed coverage on shares of Heartflow in a research note on Tuesday, September 2nd. They issued an "equal weight" rating and a $35.00 price objective for the company. Four equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $38.60.

Read Our Latest Stock Report on HTFL

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of HTFL. Hudson Bay Capital Management LP bought a new position in shares of Heartflow during the 3rd quarter worth approximately $288,000. XXEC Inc. acquired a new stake in Heartflow in the third quarter valued at approximately $1,004,000. Zimmer Partners LP purchased a new position in Heartflow in the third quarter worth $673,000. Alyeska Investment Group L.P. acquired a new position in shares of Heartflow during the third quarter worth $2,861,000. Finally, Summit Partners Public Asset Management LLC purchased a new stake in shares of Heartflow during the 3rd quarter valued at $28,559,000.

Heartflow Company Profile

(Get Free Report)

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.

Read More

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Heartflow?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Heartflow and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles